If you need more lookups,
subscriptions start at $34 USD/month.
Amy Kim Location
South San Francisco, CA, US
Amy Kim Work
VP, Head of Development Sciences @ (April 2025 - Present)
Sr Director, Research Project Leader @ (December 2023 - April 2025)
Translational Sciences Team Leader and Sr. Director @ Seagen (December 2019 - December 2023)
Head of Drug Safety (Toxicology) and Executive Director @ H3 Biomedicine (September 2015 - November 2019)
Sr Scientist and Small Molecule Oncology Therapeutic Area Leader @ (January 2006 - August 2015)
Research Fellow @ (June 2002 - January 2006)
Amy Kim Education
The University of North Carolina at Chapel Hill
PhD (Toxicology)
1997-2002
University of North Carolina at Chapel Hill
(MSPH, School of Public Health)
1991-1993
University of Virginia
(BA, English and Chemistry)
1985-1989
Amy Kim Skills
Clinical Trials
Good Laboratory Practice Glp
Translational Medicine
Small Molecules
CRO
Signal Transduction
In Vivo
Animal Models
Drug Metabolism
Biotechnology
Cell
Safety Management Systems
Clinical Study Design
Immunology
Life Sciences
Cell Culture
Inflammation
ADME
Drug Discovery
Molecular Biology
Lifesciences
Oncology
Marketing
Drug Development
Clinical Development
Monoclonal Antibodies
In Vitro
Biologics
Pharmacodynamics
Regulatory Submissions
Pharmacology
Project Management
Pharmaceutical Industry
GLP
Toxicology
Biomarkers
IND
Pharmacokinetics
Biopharmaceuticals
Good Laboratory Practice
Amy Kim Summary
Amy Kim, based in South San Francisco, CA, US, is currently a VP, Head of Development Sciences at ArriVent Biopharma. Amy Kim brings experience from previous roles at Pfizer, Seagen, H3 Biomedicine and Genentech. Amy Kim holds a 1997 - 2002 PhD in Toxicology @ The University of North Carolina at Chapel Hill. With a robust skill set that includes Clinical Trials, Good Laboratory Practice Glp, Translational Medicine, Small Molecules, CRO and more. Amy Kim has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Amy Kim?
Find contact details for 700 million professionals.